ER
Evan Lockwood Rachlin (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Iambic Therapeutics, Inc. (IAM). The largest single filing was $11.5M of IAM (718,750 sh × $16.00, as filed), executed Oct 16. The median gap between execution and disclosure was 3 days.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$11.5M
shares × price, as filed
Last traded
Oct 16
Filed Oct 19
Median ADV $40.5M across their filed names
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $11.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
IAMRecent filings
IAMPURCHASE
Iambic Therapeutics, Inc.
View filing →
$11.5M718,750 sh × $16.00
Exec Oct 16
Filed Oct 19 · 7:47 PM ET